Is this you?
Request access for Rocky Mountain Clinical Research with your @questri.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Rocky Mountain Clinical Research
Unclaimed profileSite Network · Colorado · ~2 sites
Intera lens
ICP 5Lift (cardio sample) 0.12Recruit soph 0
Quality Scorecard (1–100)
Overall82Recruit58Ops85Sponsor95Ther97
Performance (observed)
Historical trials
800
Completed
421
Terminated/Withdrawn
96
Completion rate
81%
Active now
264
Phase 2
286
Phase 3
416
Realized enrollment
544,272
First study year
1999
Years active
27
Match confidence
low (approx)
Enrollment velocity (inf)
20,158
Therapeutic
Areas
Per ClinicalTrials.gov recruiting profile
Breadth (conditions)
1,659
States
Colorado, Idaho
Recruitment (web observed)
Capability notes
3 active recruiting trials (CT.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Eli Lilly and Company; Hoffmann-La Roche; SWOG Cancer Research Network; Pfizer; Children's Oncology Group
CROs
ICON Clinical Research; MacroGenics; Medpace, Inc.; PPD Development, LP; PPD, Part of Thermo Fisher Scientific; PRA Health Sciences
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
Heather.Fasczewski@questri.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov multi-therapeutic mining. 3 active recruiting trials across 2 location(s). Website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.12Overall82
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.